Los Angeles billionaire Patrick Soon-Shiong said he plans a public stock offering for his healthcare company by year’s end, fueled by a big investment from an electronic medical records firm.

One thing we could say about the analysts on NantHealth, Inc. (NASDAQ:NH) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the ...

NantHealth, the health IT, genomics and analytics division of Dr. Patrick Soon-Shiong’s NantWorks operation, has finally filed for a long-awaited initial public offering. The IPO had been expected ...

With its stock price sinking and its financial losses piling up, Dr. Patrick Soon-Shiong’s NantHealth is reducing its headcount by about 300 staff, the company said on Thursday. The biotech ...

WINTERVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), proudly announces that its Utilization Management Program has earned a 3-year reaccreditation from the National Committee for ...

Biotech startup NantHealth launched into the market Thursday after its initial public offering, with the stock surging nearly 33 percent. The California-based company, started by billionaire physician ...

Anyone researching NantHealth, Inc. (NASDAQ:NH) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory.

Shares of biotech start-up NantHealth, run by Los Angeles billionaire physician Patrick Soon-Shiong, had a strong first day of trading Thursday, closing 32% above their offer price. The price of a ...

“The acquisition of NaviNet completes our 10-year vision at NantWorks and NantHealth to integrate and coordinate our complex healthcare ecosystem from the knowledge domain, to the care delivery domain ...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish catastrophic capital loss on anyone. Imagine if you held NantHealth, Inc. (NASDAQ:NH) for ...

The recent 10.0% drop in NantHealth, Inc.'s (NASDAQ:NH) stock could come as a blow to insiders who purchased US$5.0m worth of stock at an average buy price of US$2.96 over the past 12 months. Insiders ...

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today announced the signing of a ...